Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Regeneron priced the drug at $2,625 per single-use vial, which at least four analysts said was above their expectations. The price represents a roughly 20% premium to Roche's Vabysmo.